Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1230
-0.0070 (-5.38%)
Apr 2, 2026, 3:59 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Manufacturing and Selling of Medicines and Medical Devices
551.50M576.48M611.48M724.77M547.80M
Manufacturing and Selling of Medicines and Medical Devices Growth
-4.33%-5.72%-15.63%32.31%14.61%
Sales and Distribution of Medicines and Healthcare Products and Medical Devices
490.00M523.05M554.63M326.96M337.32M
Sales and Distribution of Medicines and Healthcare Products and Medical Devices Growth
-6.32%-5.69%69.63%-3.07%-42.95%
Elimination of Inter-Segment
-69.49M-57.83M-101.25M-65.05M-46.31M
Total
972.01M1.04B1.06B986.69M838.81M
Total Growth
-6.69%-2.18%7.92%17.63%-18.67%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
People's Republic of China (PRC)
972.01M1.04B1.06B986.69M838.81M
People's Republic of China (PRC) Growth
-6.69%-2.18%7.92%17.63%-18.67%
Total
972.01M1.04B1.06B986.69M838.81M
Total Growth
-6.69%-2.18%7.92%17.63%-18.67%
Source: S&P Global Market Intelligence.